Medivis

Medivis is a private, commercial-stage digital health company pioneering the integration of augmented reality and artificial intelligence into surgical workflows. The company's core product, SurgicalAR, is an FDA-cleared software platform that provides real-time, 3D holographic navigation for cranial and spine surgeries, with a prostate navigation system in development. With deployments in over 40 hospitals and medical schools, Medivis is positioning itself as a leader in the emerging surgical AR market, aiming to improve surgical precision, reduce operative time, and enhance patient outcomes.

SurgicalAR®: An augmented reality (AR) and artificial intelligence (AI) software platform that converts 2D medical imaging (CT, MRI) into interactive, high-fidelity 3D holograms for surgical navigation and planning. It features AI segmentation, hybrid instrument tracking, hand/voice controls, and multi-method registration.

Medivis competes in the surgical navigation and visualization market against traditional players like Medtronic (StealthStation) and Stryker (NAV3i), as well as a growing field of AR/VR-focused companies such as Augmedics, Proprio, and SentiAR. Its differentiation lies in its FDA-cleared, AR-native platform designed for intuitive spatial interaction and a lower footprint than traditional systems.